Different effects of serotonin antagonists on 3H-mianserin and 3H-ketanserin recognition sites
Creators
- 1. National Institute of Mental Health, Washington, DC
Description
In minces prepared from the frontal cortex of rats treated with ketanserin (10 mg/kg i.p.) or mianserin (5 mg/kg i.p.) twice daily for 21 days, the Vmax of the adenylate cyclase stimulated by NE (100 μM) is attenuated, suggesting that ketanserin and mianserin share with a number of antidepressants the ability to attenuate the adenylate cyclase stimulation by NE. Ketanserin, given with the above mentioned dose schedule for 7 consecutive days, reduced the Bmax of 5HT2 recognition sites but failed to change either the Bmax or the apparent Kd of 3H-mianserin binding. A significant decrease in the Bmax of 5HT2 binding sites is elicited also by a single injection of mianserin. This drug also down-regulates its own binding when given twice daily for 3 weeks. From this and other information, it is concluded that ketanserin and mianserin bind to distinct recognition sites. The possibility that 5HT2 and mianserin recognition sites are functionally related and that serotonergic synapses are modulated by multiple chemical signals might be considered. 34 references, 3 figures
Additional details
Publishing Information
- Journal Title
- Life Sci.
- Journal Volume
- 36
- Journal Issue
- 8
- Series
- Life Sci.
- Journal Page Range
- 713-721
- ISSN
- 0024-3205
- CODEN
- LIFSA
INIS
- Country of Publication
- United States
- Country of Input or Organization
- United States
- INIS RN
- 17009437
- Subject category
- S60: APPLIED LIFE SCIENCES;
- Descriptors DEI
- ANTIDEPRESSANTS; BRAIN; CHEMICAL BONDS; CYCLASES; ENZYME ACTIVITY; RATS; SEROTONIN; TRACER TECHNIQUES; TRITIUM COMPOUNDS
- Descriptors DEC
- AMINES; ANIMALS; AUTONOMIC NERVOUS SYSTEM AGENT; AZOLES; BODY; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM AGENTS; DRUGS; ENZYMES; HETEROCYCLIC COMPOUNDS; HYDROGEN COMPOUNDS; HYDROXY COMPOUNDS; INDOLES; ISOTOPE APPLICATIONS; LYASES; MAMMALS; NERVOUS SYSTEM; NEUROREGULATORS; ORGANIC COMPOUNDS; ORGANIC NITROGEN COMPOUNDS; ORGANS; PSYCHOTROPIC DRUGS; PYRROLES; RADIOPROTECTIVE SUBSTANCES; RESPONSE MODIFYING FACTORS; RODENTS; SYMPATHOMIMETICS; TRYPTAMINES; VERTEBRATES